ArticleMedical oncology (Northwood, London, England)2014

A pilot study of combination intraperitoneal recombinant human endostatin and chemotherapy for refractory malignant ascites secondary to ovarian cancer.

Jing Zhao et al.PubMed ↗Publisher ↗

No numbers read from the abstract.